Matching chemo to prostate cancer spread to internal organs
Part of Cancer, Kidney & urinary clinical trials.
This study is testing a new way to match chemotherapy drugs to your specific prostate cancer that has spread to internal organs. Doctors will grow a tiny 3D model of your tumor (organoid) in the lab and test which drugs work best for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prostate cancer has spread to internal organs like the liver or lungs (visceral metastasis).
- You are 18 years or older.
- Your active level is fairly good (able to get around on your own or with minimal help).
- Recent blood tests show your liver, kidney, and bone marrow are working normally.
- You are willing to provide a tissue sample from your cancer (via surgery or biopsy).
- You do not have severe heart, liver, kidney, nerve, or autoimmune diseases, active tuberculosis, or have had an organ transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial grows “organoids” (mini tumor models) from your lung cancer tissue to see which drug responses are most likely. It may help match future treatments to how your tumor behaves in the lab.
This trial tests if using a patient's own tumor cells grown in a lab (organoids) can help choose the best chemotherapy to put directly into the bladder. It is for people with non-muscle invasive bladder cancer who need their first round of this treatment.
This trial uses a lab test on a tiny sample of your tumor (called an organoid) to find which drug might work best for your advanced prostate cancer. It's for men whose cancer has stopped responding to hormone therapy and got worse after first treatment.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This trial uses a lab-grown miniature tumor (called an organoid) from your biopsy to test which drugs might work best for your breast cancer when standard treatments have stopped working. The goal is to find a personalized treatment option that could be more effective for you.
This study tests whether growing a patient's tumor cells in a dish (called an organoid) can help doctors choose the best next treatment. It is for people with advanced colorectal or pancreatic cancer who have run out of standard options.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.